Evoq Remedies Share Price
Small Cap | Pharmaceuticals and health care | BSE: 543500
₹5.52 -1.38 (-20.00 %)
Last Updated: 21 Feb 2025 04:01 PM
Overview
Open (₹) 7.70
High (₹) 8.28
Low (₹) 5.52
Prev. Close (₹) 6.90
Volume 21,24,000
VWAP (₹) 6.18
ROCE (%) 2.42
Industry P/E 43.99
TTM P/E 30.67
P/B Ratio 0.30
Market Cap (₹) Cr.13.74
Dividend Yield (%)--
EPS (₹) 0.03
ROE0.16%
Sales Growth (%) -80.12
Profit Growth (%)-72.06
Day Range
8.288.28
52 Week Range
5.5213.51
Historical Returns
Returns (6M)
-39.41 %
Returns (1Y)
-58.65 %
Returns (3Y)
-76.76 %
Returns (5Y)
-76.76 %
Returns (6M)
-39.41 %
Returns (1Y)
-58.65 %
Returns (3Y)
-76.76 %
Returns (5Y)
-76.76 %
SWOT Analysis
No data available
Technicals
Technical Rating
RSI 52.71
MFI 11.55
ATR 0.69
Commodity Channel Index -79.53
ROC125 -39.67
ROC21 -23.33
Williams %R -100.00
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 7.36 | 9.20 | 10.12 | 6.44 | 4.60 | 3.68 | 1.84 |
Week Ago | 6.59 | 6.61 | 6.62 | 6.58 | 6.56 | 6.55 | 6.53 |
Month Ago | 7.34 | 7.47 | 7.54 | 7.27 | 7.14 | 7.07 | 6.94 |
EMA & SMA
5.52
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 6.28
9 Day 6.56
10 Day 6.54
12 Day 6.61
14 Day 6.64
20 Day 6.77
26 Day 6.90
50 Day 7.37
100 Day 7.72
200 Day 8.79
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
SETU SECURITIES PVT. LTD. | bulk | Sell | 21 Feb, 2025 | ₹5.52 | 84,000 | BSE |
PUJABAHEN BAROT | bulk | Sell | 21 Feb, 2025 | ₹5.90 | 12,96,000 | BSE |
PRIYASHA MEVEN FINANCE LTD. | bulk | Sell | 21 Feb, 2025 | ₹5.64 | 1,36,000 | BSE |
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Sell | 21 Feb, 2025 | ₹5.52 | 68,000 | BSE |
SETU SECURITIES PVT. LTD. | bulk | Buy | 21 Feb, 2025 | ₹5.62 | 2,00,000 | BSE |
PRIYASHA MEVEN FINANCE LTD. | bulk | Buy | 21 Feb, 2025 | ₹5.62 | 1,36,000 | BSE |
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Buy | 21 Feb, 2025 | ₹5.53 | 2,00,000 | BSE |
NEETA TAYAL | bulk | Sell | 05 Jul, 2024 | ₹10.48 | 80,000 | BSE |
NISHA TAYAL | bulk | Sell | 12 Mar, 2024 | ₹10.66 | 72,000 | BSE |
NEETA TAYAL | bulk | Buy | 12 Mar, 2024 | ₹10.66 | 72,000 | BSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
12 Jan, 2024 | PAYAL BHUMISHTH PATEL | Disposal | ₹17.10705627705627705627705628 | 18,48,000 | BSE |
12 Jan, 2024 | BHUMISHTH NARENDRABHAI PATEL | Disposal | ₹16.61805228758169934640522876 | 30,60,000 | BSE |
11 Jan, 2024 | PAYAL BHUMISHTH PATEL | Disposal | ₹16.20 | 11,52,000 | BSE |
11 Jan, 2024 | BHUMISHTH NARENDRABHAI PATEL | Disposal | ₹16.20 | 11,48,000 | BSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
07 Nov, 2022 | Rights issue of equity shares of Rs. 10/- in the ratio of 18:5 @ par. | 01 Jan, 1970 | 01 Jan, 1970 |
Announcements
Date | Source | Detail |
---|---|---|
20 Feb, 2025 | BSE India | Intimation under Regulation 30 of SEBI (LODR), Regulation, 2015 |
21 Jan, 2025 | BSE India | Intimation of appointment of Statutory Auditor of the Company |
21 Jan, 2025 | BSE India | Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations,\r\n2015, we hereby inform you that the Board of Directors in their meeting held today i.e. Tuesday, 21st\r\nJanuary, 2025 at the Registered Office of the Company situated at A-1106, Empire Business Hub Near\r\nAUDA Water Tank, Science City Road, Sola, Ahmedabad - 380 060 which commenced at 05:00 P.M. and\r\nconcluded at 07:15 P.M. has considered and approved Appointment of M/s. H Thakkar & Co. LLP,\r\n(FRN: W100891), Mumbai, as the Statutory Auditor of the Company on the recommendation of Audit\r\nCommittee for the Financial Year 2024-25, subject to approval of the members in the General Meeting\r\nwithin three months from the date of appointment by the Board of Directors. |
16 Dec, 2024 | BSE India | As per Intimation attached here with. |
28 Nov, 2024 | BSE India | Kindly find the attached intimation |
14 Oct, 2024 | BSE India | Kindly find attached certificate under Regulation 74(5) of the SEBI (Depository and Participant) Regulations, 2018 |
01 Oct, 2024 | BSE India | Announcement under regulation 30 - General Announcement |
01 Oct, 2024 | BSE India | Announcement under Regulation 30 (LODR) - Resignation of Independent director |
01 Oct, 2024 | BSE India | Announcement under regulation 30 (LODR) - Change in Directorate |
01 Oct, 2024 | BSE India | Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations,\r\n2015, we hereby inform you that the Meeting Board of Directors of the Company held today i.e.,\r\nTuesday, 1st October 2024 at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road,\r\nSola Ahmedabad, Gujarat, India - 380 060 which commenced at 5:00 P.M. and concluded at 6:00 P.M.,\r\ninter-alia has considered and approved:\r\n1. Appointment of Ms. Aesha Harsh Shah (DIN: 10423365) as Additional Non-Executive\r\nIndependent Director of the Company w.e.f 1st October, 2024.\r\n2. Resignation of Mr. Pranav Manoj Vajani (DIN: 09213749) from Independent Director of the\r\nCompany w.e.f 1st October, 2024.\r\n3. Reconstitution of the Audit Committee of the Company w.e.f. 1st October, 2024\r\n4. Reconstitution of the Nomination and Remuneration Committee of the Company w.e.f. 1st October,\r\n2024 |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Audited Results | -- | 22 May, 2024 | 27 May, 2024 |
Preferential issue of shares | -- | 17 Jan, 2024 | 22 Jan, 2024 |
Half Yearly Results | (Revised) | 09 Nov, 2023 | 10 Nov, 2023 |
Half Yearly Results | -- | 09 Nov, 2023 | 08 Nov, 2023 |
Audited Results | -- | 11 May, 2023 | 25 May, 2023 |
Half Yearly Results & Rights issue | -- | 02 Nov, 2022 | 07 Nov, 2022 |
Audited Results | -- | 25 May, 2022 | 30 May, 2022 |
Share Holding Pattern
Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Sept, 2023 |
---|
About Evoq Remedies
Evoq Remedies is a Public Limited Listed company incorporated on 24/02/2010 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ2010PLC059692 and registration number is 059692. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 4.05 Cr. and Equity Capital is Rs. 13.60 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
2010
Managing Director
Mr. Bhumishth Patel
NSE Symbol
--
Evoq Remedies Management
Name | Designation |
---|---|
Mr. Bhumishth Patel | Managing Director |
Mr. Narendrakumar Patel | Non Executive Director |
Mr. Pranav Vajani | Independent Director |
Mr. Harsh Kothari | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
SunPhrmInds | ₹4,46,576.22 | ₹1,643.75 ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Evoq Remedies
What is the share price of Evoq Remedies?
The share price of Evoq Remedies on 21 Feb, 2025 is ₹ 5.52.
What is 52W high and 52W low share price of Evoq Remedies?
The highest and lowest 52W share prices of Evoq Remedies are ₹ 19.440 and ₹ 7.170
What is the market cap of Evoq Remedies?
The market capitalization of Evoq Remedies as of 21 Feb, 2025 is ₹ 13.74 Crores
What is the P/E ratio of Evoq Remedies?
The current P/E ratio of Evoq Remedies as of 21 Feb, 2025 is 43.99
What is the PB ratio of Evoq Remedies?
The PB ratio of Evoq Remedies as of 21 Feb, 2025 is 0.30
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)